| Range: | 0.48-1.57 | Vol Avg: | 620529 | Last Div: | 0 | Changes: | 0.12 |
| Beta: | 2.63 | Cap: | 0.04B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Aug 26 2021 | Empoloyees: | 71 | ||
| CUSIP: | M53071136 | CIK: | 0001584371 | ISIN: | IL0011224156 | Country: | IL |
| CEO: | Mr. Eyal Shamir | Website: | https://www.icecure-medical.com | ||||
ICCM 0.78 Stock Price IceCure Medical Ltd
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Stock Details
Positive 0.54
IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript
IceCure Medical Ltd (NASDAQ:ICCM ) Q3 2024 Earnings Conference Call November 26, 2024 10:0...
seekingalpha.com·Tue Nov 26 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow